FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124132332> ?p ?o ?g. }

• W2124132332 endingPage "4047" @default.
• W2124132332 startingPage "4038" @default.
• W2124132332 abstract "Abstract Purpose: The implication of matrix metalloproteinases (MMPs) in the major stages of cancer progression has fueled interest in the design of synthetic MMP inhibitors (MMPIs) as a novel anticancer therapy. Thus far, drugs used in clinical trials are broad-spectrum MMPIs the therapeutic index of which proved disappointingly low. The development of selective MMPIs for tumor progression-associated MMPs is, thus, likely to offer improved therapeutic possibilities. Experimental Design: The anti-invasive capacity of a series of pyrimidine-trione derivatives was tested in vitro in a chemoinvasion assay, and the most potent compound was further evaluated in vivo in different human tumor xenograft models. The activity of this novel selective MMPI was compared with BB-94, a broad-spectrum inhibitor. Results: Ro-28-2653, an inhibitor with high selectivity for MMP-2, MMP-9, and membrane type 1 (MT1)-MMP, showed the highest anti-invasive activity in vitro. In vivo, Ro-28-2653 reduced the growth of tumors induced by the inoculation of different cell lines producing MMPs and inhibited the tumor-promoting effect of fibroblasts on breast adenocarcinoma cells. Furthermore, Ro-28-2653 reduced tumor vascularization and blocked angiogenesis in a rat aortic ring assay. In contrast, BB-94 up-regulated MMP-9 expression in tumor cells and promoted angiogenesis in the aortic ring assay. Conclusion: Ro-28-2653, a selective and orally bioavailable MMPI with inhibitory activity against MMPs expressed by tumor and/or stromal cells, is a potent antitumor and antiangiogenic agent. In contrast to broad-spectrum inhibitors, the administration of Ro-28-2653 was not associated with the occurrence of adverse side effects that might hamper the therapeutic potential of these drugs." @default.
• W2124132332 created "2016-06-24" @default.
• W2124132332 creator A5020209578 @default.
• W2124132332 creator A5027945913 @default.
• W2124132332 creator A5030051484 @default.
• W2124132332 creator A5045091637 @default.
• W2124132332 creator A5046045742 @default.
• W2124132332 creator A5051462107 @default.
• W2124132332 creator A5062387212 @default.
• W2124132332 creator A5084744120 @default.
• W2124132332 creator A5089548941 @default.
• W2124132332 date "2004-06-15" @default.
• W2124132332 modified "2023-10-16" @default.
• W2124132332 title "Anti-Invasive, Antitumoral, and Antiangiogenic Efficacy of a Pyrimidine-2,4,6-trione Derivative, an Orally Active and Selective Matrix Metalloproteinases Inhibitor" @default.
• W2124132332 cites W1574172480 @default.
• W2124132332 cites W1608430181 @default.
• W2124132332 cites W1886431664 @default.
• W2124132332 cites W1968084778 @default.
• W2124132332 cites W1969123415 @default.
• W2124132332 cites W1977320698 @default.
• W2124132332 cites W1979476810 @default.
• W2124132332 cites W1980518691 @default.
• W2124132332 cites W1984483611 @default.
• W2124132332 cites W1985292800 @default.
• W2124132332 cites W2003500892 @default.
• W2124132332 cites W2008498479 @default.
• W2124132332 cites W2011134969 @default.
• W2124132332 cites W2014635418 @default.
• W2124132332 cites W2016704785 @default.
• W2124132332 cites W2016860757 @default.
• W2124132332 cites W2027322279 @default.
• W2124132332 cites W2033341544 @default.
• W2124132332 cites W2034269086 @default.
• W2124132332 cites W2037834827 @default.
• W2124132332 cites W2041233605 @default.
• W2124132332 cites W2043254359 @default.
• W2124132332 cites W204492468 @default.
• W2124132332 cites W2050039508 @default.
• W2124132332 cites W2058873146 @default.
• W2124132332 cites W2070595030 @default.
• W2124132332 cites W2074187493 @default.
• W2124132332 cites W2101960107 @default.
• W2124132332 cites W2102884576 @default.
• W2124132332 cites W2104911562 @default.
• W2124132332 cites W2105777007 @default.
• W2124132332 cites W2110384728 @default.
• W2124132332 cites W2116305904 @default.
• W2124132332 cites W2128049766 @default.
• W2124132332 cites W2134976853 @default.
• W2124132332 cites W2135330718 @default.
• W2124132332 cites W2136858036 @default.
• W2124132332 cites W2136909982 @default.
• W2124132332 cites W2140978174 @default.
• W2124132332 cites W2154390735 @default.
• W2124132332 cites W2314203153 @default.
• W2124132332 cites W24809142 @default.
• W2124132332 cites W3151254939 @default.
• W2124132332 cites W4234451634 @default.
• W2124132332 doi "https://doi.org/10.1158/1078-0432.ccr-04-0125" @default.
• W2124132332 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15217936" @default.
• W2124132332 hasPublicationYear "2004" @default.
• W2124132332 type Work @default.
• W2124132332 sameAs 2124132332 @default.
• W2124132332 citedByCount "143" @default.
• W2124132332 countsByYear W21241323322012 @default.
• W2124132332 countsByYear W21241323322013 @default.
• W2124132332 countsByYear W21241323322014 @default.
• W2124132332 countsByYear W21241323322015 @default.
• W2124132332 countsByYear W21241323322016 @default.
• W2124132332 countsByYear W21241323322017 @default.
• W2124132332 countsByYear W21241323322018 @default.
• W2124132332 countsByYear W21241323322019 @default.
• W2124132332 countsByYear W21241323322020 @default.
• W2124132332 countsByYear W21241323322021 @default.
• W2124132332 countsByYear W21241323322022 @default.
• W2124132332 countsByYear W21241323322023 @default.
• W2124132332 crossrefType "journal-article" @default.
• W2124132332 hasAuthorship W2124132332A5020209578 @default.
• W2124132332 hasAuthorship W2124132332A5027945913 @default.
• W2124132332 hasAuthorship W2124132332A5030051484 @default.
• W2124132332 hasAuthorship W2124132332A5045091637 @default.
• W2124132332 hasAuthorship W2124132332A5046045742 @default.
• W2124132332 hasAuthorship W2124132332A5051462107 @default.
• W2124132332 hasAuthorship W2124132332A5062387212 @default.
• W2124132332 hasAuthorship W2124132332A5084744120 @default.
• W2124132332 hasAuthorship W2124132332A5089548941 @default.
• W2124132332 hasBestOaLocation W21241323321 @default.
• W2124132332 hasConcept C109523444 @default.
• W2124132332 hasConcept C150903083 @default.
• W2124132332 hasConcept C185592680 @default.
• W2124132332 hasConcept C207001950 @default.
• W2124132332 hasConcept C2775958869 @default.
• W2124132332 hasConcept C2776056115 @default.
• W2124132332 hasConcept C2780394083 @default.
• W2124132332 hasConcept C502942594 @default.
• W2124132332 hasConcept C55493867 @default.
• W2124132332 hasConcept C71924100 @default.
• W2124132332 hasConcept C86803240 @default.

• next